Projected Price to Earnings: Pulmonx (LUNG)

LUNG (Pulmonx Corporation) - company brandmark

Pulmonx Corporation (LUNG) generates revenue through the sale of minimally invasive emphysema therapy systems. The issuer's forward P/E on GURU.Markets illustrates the valuation trend, where 0.00 captures the magnitude of this parameter. Growth is driven by unique patents for Zephyr valves and FDA approval, while the corporation is actively hiring sales representatives and clinical experts to achieve global scaling.

Pulmonx Corporation - LUNG Market Cap to Future Earnings Ratio (period 07/04/2022 - 11/17/2026)

Metric breakdowns and analytics for Pulmonx (LUNG)

- company stock exchange capitalization indicators:
Fundamental valuation:LUNG Pulmonx Corporation
Brand item of pulmonx.com

The forward P/E ratio compares the current market value of a share with projected net income, determining the cost of one dollar of expected earnings and the asset's level of overvaluation. By analyzing the expected price-to-earnings multiple of Pulmonx Corporation (LUNG), an investor can assess whether the quotes are fair, given the steady demand for COPD therapy, which makes the business resilient to economic cycles and reduces the risk of sharp corrections.

Competitors of Pulmonx Corporation

Forward P/E Multiple DXCM|Forward P/E Multiple Penumbra, Inc. (PEN)|Novanta Photonics - Projected Price to Earnings|Market Cap to Future Earnings Ratio HAE (Haemonetics Corporation)|INSP: Projected Price to Earnings|PROCEPT BioRobotics Corporation - Market Cap to Future Earnings Ratio|CNMD: Forward P/E Multiple|PLSE - Market Cap to Projected Earnings|INMD (inmodemd.com) - Forward P/E Multiple|PMI: Future Price to Earnings Multiple|Projected Price to Earnings SRDX (Surmodics)|SENS (Senseonics Corp) - Future Price to Earnings Multiple|Future Price to Earnings NeuroPace Medical NPCE|TCMD - Projected Price to Earnings|SANUWAVE Health - Forward P/E Multiple|Market Cap to Projected Earnings Outset Medical, Inc. OM|ELMD: Forward P/E Multiple|Price to Future Earnings Ratio LNSR|RCEL (AVITA Medical Inc) - Forward P/E Multiple|Profound Medical Corp. (PROF) - Market Cap to Projected Earnings|Forward P/E Multiple BDMD|Projected Price to Earnings EDAP TMS EDAP|Forward P/E Multiple APYX (Apyx Medical Corp)|Forward P/E Multiple IceCure Medical Ltd ICCM|TELA - Future Price to Earnings|CTSO: Future Price to Earnings|SRTS (Sensus Healthcare, Inc.) - Projected Price to Earnings|Zynex, Inc. - Future Price to Earnings Multiple|ECOR (electroCore Inc) - Forward P/E Multiple|Projected Price to Earnings Ratio vicarioussurgical.com RBOT|Future Price to Earnings Inspira Technologies (IINN)|Forward P/E Multiple SeaStar Medical Holding Corp (ICU)|IRIDEX Corp - Projected Price to Earnings|Forward P/E Multiple Intelligent Bio INBS|Beyond Air Inc - Forward P/E Multiple|Market Cap to Projected Earnings Profusa Inc. PFSA|STRATA Skin Sciences, Inc. (SSKN) - Future Price to Earnings|Price to Expected Earnings Ratio GCTK (GlucoTrack Inc.)|Future Price to Earnings nanovibronix.com|Projected Price to Earnings Venus Concept Inc. (VERO)|Forward P/E Multiple NUWE|AEMD - Projected Price to Earnings Ratio|Future Price to Earnings asensus.com ASXC|AVGR: Price to Future Earnings Ratio|BSGM: Projected Price to Earnings|Cutera, Inc. - Market Cap to Future Earnings Ratio|Know Labs Corp (KNW) - Future Price to Earnings|NARI - Market Cap to Projected Earnings|NVRO (nevro.com) - Forward P/E Multiple|Projected Price to Earnings Ratio reshapelifesciences.com RSLS|Future Price to Earnings Silk Road Medical, Inc (SILK)